MAPK3 and cutaneous squamous cell carcinoma: Knockdown of LINC00162 suppresses cell proliferation and cell migration by inhibiting ERK1/2 activity and down-regulating the expression of DUSP6 in cutaneous squamous cell carcinoma [30].